Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-2-28
pubmed:abstractText
A growing number of patients are losing their kidney allografts due to glomerulonephritis. Although posttransplant IgA nephropathy (IgAN) is regarded as benign, it may lead to late allograft loss in a substantial number of patients. The aim of this study was to evaluate the influence of posttransplant IgAN on long-term transplantation outcomes, risk factors for progression of graft dysfunction, and effectiveness of therapeutic interventions.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0041-1345
pubmed:author
pubmed:issnType
Print
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
112-4
pubmed:meshHeading
pubmed:articleTitle
IgA nephropathy in kidney allograft recipients-therapeutic perspective.
pubmed:affiliation
Transplantation Institute, Department of Transplant Medicine and Nephrology, Warsaw Medical University, Nowogrodzka 59, 02-006 Warsaw, Poland. jpazik@poczta.fm
pubmed:publicationType
Journal Article